Artelo Biosciences (ARTL) Price/OCF Ratio: History & Chart

Artelo Biosciences, Inc.(ARTL)

Biotechnology · Solana Beach, CA

$3.57+0.06 (+1.71%)

Delayed quote: Oct 6, 2026, 9:33 AM EDT

About Artelo Biosciences, Inc.

Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust developmental portfolio encompasses several promising candidates: ART27.13, a synthetic G protein-coupled receptor agonist currently undergoing Phase 1b/2a clinical investigation for cancer-related anorexia; ART12.11, a synthetic cannabidiol cocrystal being explored for inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor with potential applications in prostate and breast cancer treatment, as well as PTSD. Further extending its research efforts, Artelo has established a collaborative partnership with Trinity College Dublin to probe ART27.13's efficacy in addressing cancer cachexia. Established in 2011, the entity initially operated under the name Reactive Medical, Inc. before rebranding as Artelo Biosciences, Inc. in April 2017. Its corporate headquarters are situated in Solana Beach, California.

Solana Beach, CA

7 employees

www.artelobio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Gregory D. Gorgas

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Artelo Biosciences, Inc. (ARTL)	$1.38M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.40M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.45M	N/A	7.82	7.82	7.82
PMGC Holdings Inc. (ELAB)vs ›	$1.41M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.47M	N/A	56.34	56.34	56.34
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.50M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.17M	N/A	2.88	2.62	2.62
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.15M	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.14M	N/A	N/A	N/A	N/A
Clearmind Medicine Inc. (CMND)vs ›	$1.08M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Artelo Biosciences, Inc. (ARTL)

$1.38M

N/A

Genprex, Inc. (GNPX)vs ›

$1.40M

N/A

INVO Fertility, Inc. (IVF)vs ›

$1.45M

N/A

7.82

PMGC Holdings Inc. (ELAB)vs ›

$1.41M

N/A

Curis, Inc. (CRIS)vs ›

$1.47M

N/A

56.34

Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›

$1.50M

N/A

IM Cannabis Corp. (IMCC)vs ›

$1.17M

N/A

2.88

2.62

Jupiter Neurosciences, Inc. (JUNS)vs ›

$1.15M

N/A

Cellyan Biotechnology Co., Ltd (HKPD)vs ›

$1.14M

N/A

Clearmind Medicine Inc. (CMND)vs ›

$1.08M

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

ARTL Price/OCF Ratio Metrics

ARTL Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics